XEROX CORP 4
4 · XEROX CORP · Filed Aug 12, 2013
Insider Transaction Report
Form 4
XEROX CORPXRX
BLODGETT LYNN
Executive Vice President
Transactions
- Exercise/Conversion
Common Stock
2013-08-08$6.33/sh+117,560$744,155→ 320,527 total - Sale
Common Stock
2013-08-08$9.92/sh−117,560$1,165,748→ 202,967 total - Exercise/Conversion
Common Stock
2013-08-09$7.10/sh+200,000$1,420,000→ 402,967 total - Exercise/Conversion
Stock Options
2013-08-09−200,000→ 152,358 totalExercise: $7.10From: 2010-02-05Exp: 2017-08-15→ Common Stock (200,000 underlying) - Exercise/Conversion
Common Stock
2013-08-08$7.10/sh+204,483$1,451,829→ 407,450 total - Exercise/Conversion
Stock Options
2013-08-08−117,560→ 850,235 totalExercise: $6.33From: 2010-02-05Exp: 2019-08-20→ Common Stock (117,560 underlying) - Exercise/Conversion
Stock Options
2013-08-08−204,483→ 352,358 totalExercise: $7.10From: 2010-02-05Exp: 2017-08-15→ Common Stock (204,483 underlying) - Sale
Common Stock
2013-08-08$10.01/sh−72,043$721,150→ 202,967 total - Sale
Common Stock
2013-08-08$9.92/sh−132,440$1,313,302→ 275,010 total - Sale
Common Stock
2013-08-09$9.99/sh−200,000$1,999,000→ 202,967 total
Footnotes (1)
- [F1]These options vest and become excercisable as follows: on each anniversary date of the grant, commencing with the first such anniversary date and continuing on each such anniversary thereafter through and including the fifth anniversary of the date of the grant, 20% of such options shall vest and become excercisable. The date of the grant is 10 years prior to the stated expiration date.